A plain language summary of the 7-year update from part 1 of the COLUMBUS study: encorafenib and binimetinib for people with BRAF V600-mutant melanoma.
Journal: Future Oncology (London, England)
Published:
Authors
Dirk Schadendorf, Reinhard Dummer, Keith Flaherty, Caroline Robert, Ana Arance, Jan Willem De Groot, Claus Garbe, Helen Gogas, Ralf Gutzmer, Ivana Krajsová, Liszkay, Carmen Loquai, Mario Mandalà, Naoya Yamazaki, Paola Queirolo, Carolin Guenzel, Anna Polli, Mahgull Thakur, Alessandra Di Pietro, Paolo Ascierto
Relevant Conditions